Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Clinical Significance of Spatial Heterogeneity in Newly Diagnosed and Relapsed Multiple Myeloma

Blood (2021) 138 (Supplement 1): 1607.

https://doi.org/10.1182/blood-2021-152427

Published: 2021

Journal Articles

Spatiotemporal Assessment of Immunogenomic Heterogeneity in Multiple Myeloma

Blood (2020) 136 (Supplement 1): 14–15.

https://doi.org/10.1182/blood-2020-142622

Published: 2020

Journal Articles

Ofatumumab Plus Hypercvad/MA Induction Leads to High Rates of Minimal Residual Disease (MRD) Negativity in Patients with Newly Diagnosed Mantle Cell Lymphoma, Results of a Phase 2 Study

Pallawi Torka, MD, Nishitha Reddy, MD, Adrienne Groman, MS, Angela Kader, Jenna Nichols, Alan Hutson, Cory Mavis, MSc, Joseph Dennis Tario, PhD, Paul K. Wallace, MS, PhD, AnneMarie W. Block, PhD, Sheila N. J. Sait, PhD, Bora E Baysal, MD PhD, Vishala T. Neppalli, MD, Suchitra Sundaram, MD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2019) 134 (Supplement_1): 2817.

https://doi.org/10.1182/blood-2019-123488

Published: 2019

Journal Articles

National Survey Demonstrates Practice Gaps in Cytogenetic and Molecular Testing in Acute Myeloid Leukemia

Jessica K. Altman, MD, Ellen Denzen, MS, AnneMarie W. Block, PhD, Robert P. Hasserjian, MD, Heidi Klepin, MD, Bruno C Medeiros, MD, Amanda Noe, Wendy E Scales, PhD, Martin S. Tallman, MD, Kathleen Wiley, RN MSN AOCNS, Linda J. Burns, MD

Blood (2017) 130 (Supplement 1): 5602.

https://doi.org/10.1182/blood.V130.Suppl_1.5602.5602

Published: 2017

Journal Articles

Disease Progression on Ibrutinib Therapy Is Associated with a Poor Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) Patients Managed in Standard Clinical Practice

Othman S. Akhtar, MD, Pallawi Torka, MD, Seema A. Bhat, MD, Ryan Hare, Sheila N. J. Sait, PhD, AnneMarie W. Block, PhD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2017) 130 (Supplement 1): 5350.

https://doi.org/10.1182/blood.V130.Suppl_1.5350.5350

Published: 2017

Journal Articles

A Phase 1/2 Study of Carfilzomib Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide (C-RICE) in Patients with Transplant-Eligible, Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Pallawi Torka, MD, Seema Bhat, Kelvin P. Lee, MD, Alan Hutson, Jenna Nichols, Angela Kader, Cory Mavis, MSc, AnneMarie W Block, Sheila N. J. Sait, PhD, Bora E Baysal, MD PhD, Fadi Habib, MD, Vishala T. Neppalli, MD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2017) 130 (Supplement 1): 2822.

https://doi.org/10.1182/blood.V130.Suppl_1.2822.2822

Published: 2017

Journal Articles

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Blood (2015) 126 (23): 2621.

https://doi.org/10.1182/blood.V126.23.2621.2621

Published: 2015

Journal Articles

Intense Cytarabine-Based Chemo-Immunotherapy, Central Nervous System (CNS) Prophylaxis and Early High-Dose Chemotherapy and Autologous Stem Cell Support (HDC-ASCS) in First Remission Are Associated with an Improved Clinical Outcome in Double-Hit (DHL)/Triple-Hit (THL) Diffuse Large B-Cell Lymphoma (DLBCL)

Priyank P. Patel, MD, Pallawi Torka, MD, Vishala T. Neppalli, MD, George Deeb, MD, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, Seema A. Bhat, MD, Myron S. Czuczman, MD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2014) 124 (21): 3031.

https://doi.org/10.1182/blood.V124.21.3031.3031

Published: 2014

Journal Articles

Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts)

Blood (2011) 118 (21): 414.

https://doi.org/10.1182/blood.V118.21.414.414

Published: 2011

Journal Articles

Smoking Adversely Affects Survival in Acute Myeloid Leukemia Patients.

Ramya Varadarajan, MD, Andrea Licht, MS, Andrew J. Hyland, PhD, Laurie Ann Ford, Maurice Barcos, MD, PhD, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, Maria R. Baer, MD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 979.

https://doi.org/10.1182/blood.V114.22.979.979

Published: 2009

Journal Articles

Myeloid Blastic Transformation of Myeloproliferative Neoplasms – A Review of 113 Cases.

Syed Noor, MD, Wei Tan, PhD, Gregory Wilding, PhD, Laurie Ann Ford, Maurice Barcos, MD, PhD, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 3113.

https://doi.org/10.1182/blood.V114.22.3113.3113

Published: 2009

Journal Articles

CD33-Negative Acute Myeloid Leukemia (AML) Has Similar Characteristics to CD33-Positive Disease.

Cecilia Y. Arana Yi, MD, Wei Tan, Ph.D., Gregory Wilding, Ph.D., Laurie Ann Ford, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, George Deeb, MD, Paul K. Wallace, MS, PhD, Petr Starostik, MD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 4129.

https://doi.org/10.1182/blood.V114.22.4129.4129

Published: 2009

Journal Articles

Concomitant Presentation of Acute Myeloid Leukemia (AML) and Lung Cancer

Ramya Varadarajan, MD, LaurieAnn Ford, Sheila NJ Sait, Annemarie W. Block, PhD, Maurice Barcos, MD, PhD, Paul K. Wallace, MS, PhD, Nithya Ramnath, Eunice S Wang, Meir Wetzler, MD

Blood (2008) 112 (11): 3994.

https://doi.org/10.1182/blood.V112.11.3994.3994

Published: 2008

Journal Articles

Fluorescence Activated Cell Sorting (FACS) Followed by Fluorescence In Situ Hybridization (FISH) To Determine Clonal Origins of Cells in Myelodysplastic Syndrome (MDS) with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Minoo Battiwalla, MD, Sheila Sait, Ph.D., AnneMarie W. Block, Ph.D., Ibrahim Kebbewar, Ph.D., Manmeet S. Ahluwalia, M.D., Earl A. Timm, Ph.D., Paul K. Wallace, Ph.D.

Blood (2007) 110 (11): 4623.

https://doi.org/10.1182/blood.V110.11.4623.4623

Published: 2007

Journal Articles

Low Incidence of Deletions of ATM (ataxia-telangiectasia mutated) Gene in Patients (pts) with Multiple Myeloma (MM) as Detected by FISH.

Asher Alban Chanan-Khan, MD, Kena Miller, NP, Philip McCarthy, MD, Joanna M. Panasiewicz, AnneMarie W. Block, Ph.D.

Blood (2004) 104 (11): 4886.

https://doi.org/10.1182/blood.V104.11.4886.4886

Published: 2004

Journal Articles

Central Review of Cytogenetics Is Essential for Cooperative Group Clinical and Correlative Studies of Acute Leukemia: The Cancer and Leukemia Group B (CALGB) 8461 Experience.

Krzysztof Mrózek, Andrew J. Carroll, Kati Maharry, Kathleen W. Rao, Shivanand R. Patil, Mark J. Pettenati, Michael S. Watson, Diane C. Arthur, Ramana Tantravahi, Nyla A. Heerema, Prasad R.K. Koduru, Sandra H. Bigner, Judith Stamberg, AnneMarie W. Block, Colin G. Edwards, Lisa J. Sterling, Clara D. Bloomfield

Blood (2004) 104 (11): 1081.

https://doi.org/10.1182/blood.V104.11.1081.1081

Published: 2004

Journal Articles

Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience

Meir Wetzler, Richard K. Dodge, Krzysztof Mrózek, Andrew J. Carroll, Ramana Tantravahi, AnneMarie W. Block, Mark J. Pettenati, Michelle M. Le Beau, Stanley R. Frankel, Carleton C. Stewart, Ted P. Szatrowski, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield

Blood (1999) 93 (11): 3983–3993.

https://doi.org/10.1182/blood.V93.11.3983

Published: 1999

Journal Articles

ETV6-AML1 Translocation Breakpoints Cluster Near a Purine/Pyrimidine Repeat Region in the ETV6 Gene

Srinivas P. Thandla, Jonathan E. Ploski, Samina Z. Raza-Egilmez, Pradheepkumar P. Chhalliyil, AnneMarie W. Block, Pieter J. de Jong, Peter D. Aplan

Blood (1999) 93 (1): 293–299.

https://doi.org/10.1182/blood.V93.1.293

Published: 1999

NARROW

Clinical Significance of Spatial Heterogeneity in Newly Diagnosed and Relapsed Multiple Myeloma

Spatiotemporal Assessment of Immunogenomic Heterogeneity in Multiple Myeloma

Ofatumumab Plus Hypercvad/MA Induction Leads to High Rates of Minimal Residual Disease (MRD) Negativity in Patients with Newly Diagnosed Mantle Cell Lymphoma, Results of a Phase 2 Study

National Survey Demonstrates Practice Gaps in Cytogenetic and Molecular Testing in Acute Myeloid Leukemia

Disease Progression on Ibrutinib Therapy Is Associated with a Poor Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) Patients Managed in Standard Clinical Practice

A Phase 1/2 Study of Carfilzomib Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide (C-RICE) in Patients with Transplant-Eligible, Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Prognostic Utility of the European LeukemiaNet (ELN) Genetic-Risk Classification in Adults with De Novo Acute Myeloid Leukemia (AML): A Study of 1,550 Patients (Pts)

Smoking Adversely Affects Survival in Acute Myeloid Leukemia Patients.

Myeloid Blastic Transformation of Myeloproliferative Neoplasms – A Review of 113 Cases.

CD33-Negative Acute Myeloid Leukemia (AML) Has Similar Characteristics to CD33-Positive Disease.

Concomitant Presentation of Acute Myeloid Leukemia (AML) and Lung Cancer

Fluorescence Activated Cell Sorting (FACS) Followed by Fluorescence In Situ Hybridization (FISH) To Determine Clonal Origins of Cells in Myelodysplastic Syndrome (MDS) with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Low Incidence of Deletions of ATM (ataxia-telangiectasia mutated) Gene in Patients (pts) with Multiple Myeloma (MM) as Detected by FISH.

Central Review of Cytogenetics Is Essential for Cooperative Group Clinical and Correlative Studies of Acute Leukemia: The Cancer and Leukemia Group B (CALGB) 8461 Experience.

Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience

ETV6-AML1 Translocation Breakpoints Cluster Near a Purine/Pyrimidine Repeat Region in the ETV6 Gene

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only